KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 162 filers reported holding KURA ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $234,000 | -67.9% | 7,642 | -82.9% | 0.16% | -68.9% |
| Q2 2020 | $729,000 | -27.0% | 44,708 | -55.4% | 0.53% | -40.2% |
| Q1 2020 | $998,000 | +13.3% | 100,329 | +56.6% | 0.88% | +13.4% |
| Q4 2019 | $881,000 | +6.7% | 64,059 | +17.7% | 0.78% | -4.2% |
| Q3 2019 | $826,000 | -16.4% | 54,430 | +8.5% | 0.81% | -9.6% |
| Q2 2019 | $988,000 | +308.3% | 50,159 | +190.8% | 0.90% | +251.2% |
| Q4 2018 | $242,000 | – | 17,250 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |